michigan glp-1 lawsuit Novo CEO outlines long-term strategy amid Trump-era drug talks: ‘We’re here to stay’ GLP-1 Lawsuit Lawyer

doi: 10.1038/nrgastro.2014.66 64 HuangH.LiK.LeeY.ChenM

New England Journal of Medicine , (Forthcoming/ePub ahead of print - based on recent trial results)

That behavioral foundation appears to slow post-discontinuation regain relative to patients who relied on medication alone, though no head-to-head comparison of taper strategies by behavioral history exists yet

Doses reflect commonly used ranges in current research and supplement labelling, not a personal prescription

Results indicate that combination therapies yield significant therapeutic benefits for managing thyroid disorders, suggesting that plant-based medicines may offer multi-target effects with gentler efficacy profiles

Safety considerations Pregnancy and breastfeeding: Not recommended